PHL-DOXYCYCLINE CAPSULE

Страна: Канада

Язык: английский

Источник: Health Canada

Активный ингредиент:

DOXYCYCLINE (DOXYCYCLINE HYCLATE)

Доступна с:

PHARMEL INC

код АТС:

J01AA02

ИНН (Международная Имя):

DOXYCYCLINE

дозировка:

100MG

Фармацевтическая форма:

CAPSULE

состав:

DOXYCYCLINE (DOXYCYCLINE HYCLATE) 100MG

Администрация маршрут:

ORAL

Штук в упаковке:

100

Тип рецепта:

Prescription

Терапевтические области:

TETRACYCLINES

Обзор продуктов:

Active ingredient group (AIG) number: 0105569001; AHFS:

Статус Авторизация:

CANCELLED POST MARKET

Дата Авторизация:

2016-10-25

Характеристики продукта

1
PRODUCT MONOGRAPH
PR
phl
-
DOXYCYCLINE
(Doxycycline Hyclate Tablets, USP)
100 mg tablets
(Doxycycline Hyclate Capsules, USP)
100 mg capsules
Antibiotic
Pharmel Inc.
Date of Preparation:
6111, Royalmount Ave, Suite #100
December 12, 2006
Montréal, Quebec H4P 2T4
Control # 110390
2
NAME OF DRUG
phl-DOXYCYCLINE
(Doxycycline Hyclate Tablets, USP)
(Doxycycline Hyclate Capsules, USP)
THERAPEUTIC CLASSIFICATION
Antibiotic
ACTION
Doxycycline hyclate is a broad-spectrum antibiotic, which is active
against a wide range of
Gram-negative and Gram-positive organisms. Doxycycline hyclate exerts
its bacteriostatic effect by
inhibition of protein synthesis
5
.
INDICATIONS AND CLINICAL USE
phl-DOXYCYCLINE (doxycycline hyclate) may be indicated for the
treatment of:
PNEUMONIA
: Single and multilobe pneumonia and bronchopneumonia due to
susceptible strains of
Streptococcus
pneumoniae
(formerly
Diplococcus
pneumoniae)
and
other
Streptococci,
Staphylococcus, H. influenzae and Klebsiella pneumoniae.
OTHER RESPIRATORY TRACT INFECTIONS
: Pharyngitis, tonsillitis, sinusitis, otitis media, bronchitis
caused by susceptible strains of beta-hemolytic Streptococcus,
Staphylococcus, Streptococcus
pneumoniae (formerly Diplococcus pneumoniae) and H. influenzae.
3
GENITOURINARY TRACT INFECTIONS
: Pyelonephritis, cystitis, urethritis, gonococcal urethritis caused
by
susceptible
strains
of
Klebsiella
species,
Enterobacter
aerogenes,
E.
coli,
Enterococcus,
Staphylococcus, Streptococcus and Neisseria gonorrhoeae.
Clinical resolution and absence of detectable organisms have been
observed at the
completion of oral doxycycline hyclate therapy in adult patients with
urethritis, cervicitis and
vaginitis and having positive tests for Chlamydia trachomatis and/or
Ureaplasma urealyticum.
Relapses or reinfection can occur. In these cases, limited data
suggest that some patients may derive
clinical benefit from oral administration of doxycycline hyclate or an
alternative therapy. The effect
on long-term morbidity has not been established.
SKIN AND SOFT TISS